PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis

PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis

Abstract Background We present a systematic review and meta‐analysis of randomized clinical trials (RCTs) with PARPi either as monotherapy or in combination with an androgen receptor‐targeted agent (ARTA) in first‐ and second‐line settings. Methods Primary endpoints are radiographic progression free...

Full description

Saved in:

Bibliographic Details
Main Authors:	Michela Roberto, Mattia Alberto Di Civita, Daniele Marinelli, Andrea Torchia, Nertila Cara, Giulia Maltese, Iolanda Speranza, Daniele Santini
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	BJUI Compass
Subjects:	androgen receptor signalling inhibitor (ARSI) androgen receptor‐targeted agents (ARTA) BRCA DNA damage repair defects (DDR) homologous recombination repair (HRR) poly‐ADP ribose polymerase (PARP) inhibitors
Online Access:	https://doi.org/10.1002/bco2.455
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Treatment-related Hypertension as a Prognostic Factor for De Novo Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Real-world Evidence Study
by: Giuseppe Salfi, et al.
Published: (2025-01-01)

Comparative analysis of the primary structure and production of recombinant poly(ADP-ribose)polymerase 1 of long-lived Heterocephalus glaber
by: K. N. Naumenko, et al.
Published: (2024-11-01)

Hormone Receptors in Cervicovaginal Cells
by: Şayeste Demirezen, et al.
Published: (2013-04-01)

Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors
by: Romain Pacaud, et al.
Published: (2025-01-01)

Interaction of RECQL4 with poly(ADP‐ribose) is critical for the DNA double‐strand break response in human cells
by: Sunyoung Shin, et al.
Published: (2025-01-01)

Blast‐Overpressure Induced Modulation of PARP‐SIRT‐NRF2 Axis in Stress Signaling of Astrocytes and Microglia
by: Vijaya Prakash Krishnan Muthaiah, et al.
Published: (2025-01-01)

Looking beyond the ER, PR, and HER2: what’s new in the ARsenal for combating breast cancer?
by: Tryambak Pratap Srivastava, et al.
Published: (2025-01-01)

Real-world treatment patterns and survival outcomes in men with metastatic castration-resistant prostate cancer in Finland: a national, population-based cohort study
by: Antti Rannikko, et al.
Published: (2025-01-01)

Androgen receptor overexpression by immunohistochemistry in malignant salivary gland tumors in Tanzania
by: Subira Matiku, et al.
Published: (2025-01-01)

A comprehensive comparison of PARP inhibitors as maintenance therapy in platinum-sensitive recurrent ovarian cancer: a systematic review and network meta-analysis
by: Shiya Ji, et al.
Published: (2025-01-01)

Secondary Cancer after Androgen Deprivation Therapy in Prostate Cancer: A Nationwide Study
by: Jae Heon Kim, et al.
Published: (2025-01-01)

Cell-specific functions of androgen receptor in skeletal muscles
by: Hiroshi Sakai, et al.
Published: (2024-05-01)

Relationship between androgen receptor and androgen receptor-related protein expression in breast cancers focusing on morphologically identified carcinoma with apocrine differentiation
by: Haruto Nishida, et al.
Published: (2025-01-01)

AR and YAP crosstalk: impacts on therapeutic strategies in prostate cancer
by: Guansong Zheng, et al.
Published: (2025-02-01)

Repression of PFKFB3 sensitizes ovarian cancer to PARP inhibitors by impairing homologous recombination repair
by: Yinan Xiao, et al.
Published: (2025-01-01)

Lathyrol affects the expression of AR and PSA and inhibits the malignant behavior of RCC cells
by: Song Shengyou, et al.
Published: (2025-02-01)

Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance
by: Caihong Li, et al.
Published: (2025-02-01)

Advancements in Research on Non-AR- Signaling Pathways and Targeted Therapies for Castration-Resistant Prostate Cancer
by: Haq Dad, et al.
Published: (2025-01-01)

The relationship between mutation carriage of BRCA1/2 and clinicopathological characteristics in women with breast cancer – experience from a diagnostic centre in Turkey
by: Neslihan Duzkale, et al.
Published: (2024-09-01)

Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer
by: Maurizio Capuozzo, et al.
Published: (2024-05-01)

Research trends in glioma chemoradiotherapy resistance: a bibliometric analysis (2003–2023)
by: Shishi Yu, et al.
Published: (2025-02-01)

Feasibility of enzalutamide on patients with recurrent non-muscle-invasive bladder cancer with marker tumors: phase I study
by: Takashi Kawahara, et al.
Published: (2025-01-01)

Meta-analyses of mouse and human prostate single-cell transcriptomes reveal widespread epithelial plasticity in tissue regression, regeneration, and cancer
by: Luis Aparicio, et al.
Published: (2025-01-01)

Steroid hormone receptors, exome sequencing and treatment responsiveness of breast cancer patient-derived xenografts originated in a South American country
by: Gabriela Pataccini, et al.
Published: (2025-01-01)

The 340B Drug Pricing Program and Management of Advanced Prostate Cancer
by: Kassem S. Faraj, et al.
Published: (2025-01-01)

Community pharmacy’s role in dispensing androgens and supporting harm reduction amid current policy dilemmas
by: Timothy Piatkowski, et al.
Published: (2025-01-01)

Uridine-cytidine kinase 2 is correlated with immune, DNA damage repair and promotion of cancer stemness in pan-cancer
by: Jinlong Tian, et al.
Published: (2025-01-01)

Dual Functions of Androgen Receptor Overexpression in Triple-Negative Breast Cancer: A Complex Prognostic Marker
by: Umay Kiraz, et al.
Published: (2025-01-01)

Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers
by: Hua Huang, et al.
Published: (2025-02-01)

ECM-mimicking hydrogel models of human adipose tissue identify deregulated lipid metabolism in the prostate cancer-adipocyte crosstalk under antiandrogen therapy
by: Agathe Bessot, et al.
Published: (2025-02-01)

Health Implications of Anabolic-Androgenic Steroids: Usage, Risks, and Treatment Approaches - The Literature Review
by: Krzysztof Jodłowski, et al.
Published: (2025-02-01)

Ovarian Sclerosing Stromal Tumour Associated with Hirsutism in an Adolescent
by: Mehmet Dolanbay, et al.
Published: (2014-12-01)

The correlation between the expression of androgen receptor splice variant-7 (AR-V7) protein with the time of occurrence of castration-resistant prostate cancer and overall survival in prostate cancer in Indonesian population
by: Indrawarman Soerohardjo, et al.
Published: (2025-02-01)

Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway
by: Young-Jin Choi, et al.
Published: (2024-05-01)

A Cross-sectional Survey of Physicians to Understand Biomarker Testing and Treatment Patterns in Patients with Prostate Cancer in the USA, EU5, Japan, and China
by: Christian Gratzke, et al.
Published: (2025-01-01)

Effect of Basal Testosterone and Dehydroepiandrosterone Sulphate Levels on in Vitro Fertilization Outcome in Normoresponders
by: İnci Kahyaoğlu, et al.
Published: (2013-12-01)

A case of de novo neuroendocrine prostate cancer presented with elevated level of serum CEA carrying BRCA2 mutation: case report and literature review
by: Weizhe Han, et al.
Published: (2025-01-01)

Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression
by: Jasper Van Goubergen, et al.
Published: (2025-02-01)

Use of Anabolic-Androgenic Steroids and Male Fertility: A Systematic Review and Meta-analysis
by: Prashant Motiram Mulawkar, et al.
Published: (2023-10-01)

An Overview of the Deadly Effects of Anabolic-Androgenic Steroids: Clinical Cases and Scientific Insights
by: Maciej Mossakowski, et al.
Published: (2025-01-01)